To further evaluate the incidence of TAZ mutations in pediatric cardiomyopathy, we performed mutational analysis in a large cohort of unselected pediatric patients with primary cardiomyopathy and identified TAZ mutations in 4/114 (3.5%) male index patients. The gene discussed is TAFAZZIN; the disease is intrinsic cardiomyopathy.